Amanote Research
Register
Sign In
P3.13-12 a Lung Adenocarcinoma With Concomitant EGFR and De Novo MET Amplification Response Well to Combination of TKI and Bevacizumab
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1852
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
Q. Chu
J. Jiang
S. Huang
P. Zhang
Y. Chen
Publisher
Elsevier BV
Related search
Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
Molecular Cancer Therapeutics
Cancer Research
Oncology
Precision Medicine Approaches to Lung Adenocarcinoma With Concomitant MET and HER2 Amplification
BMC Cancer
Cancer Research
Oncology
Genetics
P3.13-13 Afatinib in Lung Adenocarcinoma Harboring De Novo EGFR Exon 20 Insertions.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Case of EGFR Mutant Lung Adenocarcinoma That Acquired Resistance to EGFR-tyrosine Kinase Inhibitors With MET Amplification and Epithelial-To-Mesenchymal Transition
OncoTargets and Therapy
Oncology
Pharmacology
P2.13-12 the deNovo T790M Mutation Recovered by ddPCR Is Associated With a Poor Response to 1st and 2nd Generation EGFR-TKI in Lung Adenocarcinoma.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.13-08 Assessment of EGFR Gene Mutations in Cf-Dna in Monitoring of Response to EGFR TKIs in Patients With Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
EGFR-TKI and Lung Adenocarcinoma With CNS Relapse: Interest of Molecular Follow-Up
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
P063 STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-60 a Novel MET D1246H Mutation After Progression of EGFR-TKI/MET Inhibitor Combined Therapy in a NSCLC Patient With Acquired MET Amplification
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary